Literature DB >> 12665650

Loss of heterozygosity mutations of tumor suppressor genes in cytologically atypical areas in chronic lymphocytic thyroiditis.

Jennifer L Hunt1, Zubair W Baloch, Leon Barnes, Patricia A Swalsky, Cindy L Trusky, E Sesatomi, Sydney Finkelstein, Virginia A LiVolsi.   

Abstract

The relationship between chronic lymphocytic thyroiditis (CLT) and papillary thyroid carcinoma (PTC) is a subject of controversy. Some investigators suggest a causal relationship, whereas others regard the two as only a coincidental occurrence. An additional complicating factor is the presence of atypical nuclei frequently found within lymphoid infiltrates in CLT, which resemble those in PTC. The finding of the RET-PTC translocations in CLT has been reported by two independent groups of investigators, suggesting that the areas of nuclear atypia in CLT are neoplastic rather than reactive. In the present study, we report additional molecular findings that support the hypothesis that the atypical nuclear changes in CLT may be preneoplastic or neoplastic. We microdissected small areas with atypical nuclei in glands with CLT and observed loss-of-heterozygosity mutations of tumor suppressor genes. These genetic mutations are evidence of clonal preneoplastic or neoplastic changes in the follicular cells of CLT. The clinical malignant potential of these minute foci is likely to be very small but remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12665650     DOI: 10.1385/ep:13:4:321

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  37 in total

1.  Differential expression of cytokeratins in follicular variant of papillary carcinoma: an immunohistochemical study and its diagnostic utility.

Authors:  Z W Baloch; S Abraham; S Roberts; V A LiVolsi
Journal:  Hum Pathol       Date:  1999-10       Impact factor: 3.466

2.  Immunohistochemical diagnosis of papillary thyroid carcinoma.

Authors:  C C Cheung; S Ezzat; J L Freeman; I B Rosen; S L Asa
Journal:  Mod Pathol       Date:  2001-04       Impact factor: 7.842

3.  ret/PTC-1 Activation in Hashimoto Thyroiditis.

Authors:  O. M. Sheils; J.J. O'eary; V. Uhlmann; K. Lättich; E. C. Sweeney
Journal:  Int J Surg Pathol       Date:  2000-07       Impact factor: 1.271

4.  Prognostic significance of RET and NTRK1 rearrangements in sporadic papillary thyroid carcinoma.

Authors:  T J Musholt; P B Musholt; N Khaladj; D Schulz; G F Scheumann; J Klempnauer
Journal:  Surgery       Date:  2000-12       Impact factor: 3.982

5.  Detection of the PTC/retTPC oncogene in human thyroid cancers.

Authors:  S M Jhiang; D R Caruso; E Gilmore; Y Ishizaka; T Tahira; M Nagao; I M Chiu; E L Mazzaferri
Journal:  Oncogene       Date:  1992-07       Impact factor: 9.867

6.  Pathologic features of Hashimoto's-associated papillary thyroid carcinomas.

Authors:  M Di Pasquale; J L Rothstein; J P Palazzo
Journal:  Hum Pathol       Date:  2001-01       Impact factor: 3.466

7.  Struma lymphomatosa and carcinoma of the thyroid.

Authors:  G Crile
Journal:  Surg Gynecol Obstet       Date:  1978-09

8.  Cancer risks in patients with chronic lymphocytic thyroiditis.

Authors:  L E Holm; H Blomgren; T Löwhagen
Journal:  N Engl J Med       Date:  1985-03-07       Impact factor: 91.245

9.  A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases.

Authors:  A Fusco; M Grieco; M Santoro; M T Berlingieri; S Pilotti; M A Pierotti; G Della Porta; G Vecchio
Journal:  Nature       Date:  1987 Jul 9-15       Impact factor: 49.962

10.  Papillary thyroid carcinoma oncogene (RET/PTC) alters the nuclear envelope and chromatin structure.

Authors:  A H Fischer; J A Bond; P Taysavang; O E Battles; D Wynford-Thomas
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

View more
  8 in total

Review 1.  [Inflammatory diseases of the thyroid gland].

Authors:  S Synoracki; S Ting; K W Schmid
Journal:  Pathologe       Date:  2016-05       Impact factor: 1.011

Review 2.  Aging and inflammation: etiological culprits of cancer.

Authors:  Aamir Ahmad; Sanjeev Banerjee; Zhiwei Wang; Dejuan Kong; Adhip P N Majumdar; Fazlul H Sarkar
Journal:  Curr Aging Sci       Date:  2009-12

3.  BRAF mutation is unusual in chronic lymphocytic thyroiditis-associated papillary thyroid carcinomas and absent in non-neoplastic nuclear atypia of thyroiditis.

Authors:  Rachel Sargent; Virginia LiVolsi; Justin Murphy; Geeta Mantha; Jennifer L Hunt
Journal:  Endocr Pathol       Date:  2006       Impact factor: 3.943

4.  Follicular epithelial dysplasia of the thyroid: morphological and immunohistochemical characterization of a putative preneoplastic lesion to papillary thyroid carcinoma in chronic lymphocytic thyroiditis.

Authors:  Michael Herman Chui; Clarissa A Cassol; Sylvia L Asa; Ozgur Mete
Journal:  Virchows Arch       Date:  2013-03-27       Impact factor: 4.064

5.  Coexistence of chronic lymphocytic thyroiditis with papillary thyroid carcinoma: clinical manifestation and prognostic outcome.

Authors:  Jun Soo Jeong; Hyun Ki Kim; Cho-Rok Lee; Seulkee Park; Jae Hyun Park; Sang-Wook Kang; Jong Ju Jeong; Kee-Hyun Nam; Woong Youn Chung; Cheong Soo Park
Journal:  J Korean Med Sci       Date:  2012-07-25       Impact factor: 2.153

6.  Expression microarray analysis of papillary thyroid carcinoma and benign thyroid tissue: emphasis on the follicular variant and potential markers of malignancy.

Authors:  S P Finn; P Smyth; S Cahill; C Streck; E M O'Regan; R Flavin; J Sherlock; D Howells; R Henfrey; M Cullen; M Toner; C Timon; J J O'Leary; O M Sheils
Journal:  Virchows Arch       Date:  2007-01-25       Impact factor: 4.064

7.  The effect of chronic lymphocytic thyroiditis on patients with thyroid cancer.

Authors:  Yi Zhang; Xiao-Peng Ma; Fu-Sheng Deng; Zheng-Rong Liu; Hou-Qing Wei; Xi-Hong Wang; Hao Chen
Journal:  World J Surg Oncol       Date:  2014-09-01       Impact factor: 2.754

8.  Detection and molecular characterisation of thyroid cancer precursor lesions in a specific subset of Hashimoto's thyroiditis.

Authors:  A Gasbarri; S Sciacchitano; A Marasco; M Papotti; A Di Napoli; A Marzullo; P Yushkov; L Ruco; A Bartolazzi
Journal:  Br J Cancer       Date:  2004-09-13       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.